We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-23.25%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$358M
AUM Growth
-$182M
(-34%)
Cap. Flow
-$93.5M
Cap. Flow
% of AUM
-26.12%
Top 10 Holdings %
Top 10 Hldgs %
31.98%
Holding
756
New
76
Increased
136
Reduced
196
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Poland ETF
EPOL
|
+$9.75M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$8.54M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$7.11M |
| 4 |
iShares MSCI Turkey ETF
TUR
|
+$6.88M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$6.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$24.1M |
| 2 |
Ferrari
RACE
|
+$13.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$10.2M |
| 4 |
iShares MSCI Malaysia ETF
EWM
|
+$9.43M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$8.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.9% |
| 2 | Healthcare | 11.32% |
| 3 | Technology | 9.99% |
| 4 | Financials | 8.31% |
| 5 | Consumer Discretionary | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
276
DELISTED
Blueprint Medicines
BPMC
| $104K | 0.03% |
1,770
+1,765
| +35,300% | +$114K |
|
277
ICU Medical
ICUI
$3.96B
| $102K | 0.03% |
507
+498
| +5,533% | +$95.9K |
|
278
Alcoa
AA
$12.5B
| $99K | 0.03% |
16,074
+871
| +6% | +$12K |
|
279
Outfront Media
OUT
$5.04B
| $98K | 0.03% |
7,386
+7,343
| +17,077% | +$179K |
|
|
AAN.A
280
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $97.7K | 0.03% |
4,287
-3,173
| -43% | -$72.3K |
|
281
Kura Oncology
KURA
$1.01B
| $96.6K | 0.03% |
+9,705
| New | +$111K |
|
282
State Street SPDR S&P Metals & Mining ETF
XME
$4.51B
| $95.2K | 0.03% |
+5,900
| New | +$137K |
|
|
CDTX
283
DELISTED
Cidara Therapeutics
CDTX
| $94.8K | 0.03% |
+1,911
| New | +$115K |
|
284
Dollar Tree
DLTR
$21.6B
| $93.5K | 0.03% |
1,273
+1,268
| +25,360% | +$108K |
|
|
MASI
285
DELISTED
Masimo
MASI
| $93.3K | 0.03% |
+527
| New | +$90.4K |
|
|
XLNX
286
DELISTED
Xilinx Inc
XLNX
| $93.2K | 0.03% |
1,196
| – | – |
|
|
ONC
287
BeOne Medicines Ltd
ONC
$39.2B
| $92.3K | 0.03% |
+750
| New | +$117K |
|
|
IGMS
288
DELISTED
IGM Biosciences
IGMS
| $91.5K | 0.03% |
+1,630
| New | +$71.4K |
|
289
Kiniksa Pharmaceuticals
KNSA
$5.98B
| $91.2K | 0.03% |
+5,890
| New | +$92.1K |
|
290
Rhythm Pharmaceuticals
RYTM
$6.81B
| $90.7K | 0.03% |
+5,960
| New | +$107K |
|
291
Prologis
PLD
$129B
| $90.1K | 0.03% |
1,121
+7
| +0.6% | +$612 |
|
|
STSA
292
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $89.3K | 0.02% |
+4,148
| New | +$94.2K |
|
|
B
293
Barrick Mining
B
$70.8B
| $87.8K | 0.02% |
4,790
-20,192
| -81% | -$378K |
|
294
Target
TGT
$70.4B
| $87.2K | 0.02% |
938
-580
| -38% | -$64.4K |
|
295
Krystal Biotech
KRYS
$10.2B
| $87.2K | 0.02% |
+2,016
| New | +$105K |
|
296
State Street SPDR S&P Regional Banking ETF
KRE
$4.29B
| $86.8K | 0.02% |
2,665
| – | – |
|
297
Nike
NKE
$53.8B
| $86.1K | 0.02% |
1,041
+39
| +4% | +$3.63K |
|
|
EA
298
DELISTED
Electronic Arts
EA
| $85.9K | 0.02% |
858
-1,023
| -54% | -$108K |
|
|
CCXI
299
DELISTED
ChemoCentryx, Inc.
CCXI
| $85.5K | 0.02% |
+2,129
| New | +$90.4K |
|
|
APHA
300
DELISTED
Aphria Inc. Common Shares
APHA
| $84.1K | 0.02% |
27,481
+10,846
| +65% | +$43.3K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2020 Portfolio in Review
As of Q1 2020, Exane Derivatives held 756 positions worth $358M, down 34% from $540M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Exane Derivatives withdrew a net $93.5M in Q1 2020, closing 54 positions and reducing 196 holdings. Its most notable exit was Ferrari, an estimated $13.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Exane Derivatives opened a new position in VanEck Oil Services ETF worth $2.8M.
- Exane Derivatives's largest Q1 2020 buy was VanEck Oil Services ETF: 34,775 shares worth $2.8M.
- Exane Derivatives added most to iShares MSCI Poland ETF in Q1 2020, an estimated $9.75M increase.
- Exane Derivatives's biggest Q1 2020 reduction was UBS Group, cutting an estimated $24.1M.
- Exane Derivatives fully exited Ferrari in Q1 2020, selling an estimated $13.3M.
- Exane Derivatives's ten largest holdings make up 32% of its $358M portfolio in Q1 2020.
- Exane Derivatives opened 76 new positions and closed 54 in Q1 2020.
- Exane Derivatives's portfolio value fell 34% quarter-over-quarter to $358M.
Based on Exane Derivatives's 13F filing for Q1 2020, filed 17 Apr 2020.